Anti-factor VIII inhibitors against A2 and C2 domains in hemophilia A patients from India

Blood Cells Mol Dis. 2019 Mar:75:11-12. doi: 10.1016/j.bcmd.2018.11.004. Epub 2018 Nov 16.

Authors

Tejasvita Gaikwad¹, Rutuja Deshpande¹, Shrimati Shetty²

Affiliations

¹ Department of Hemostasis and Thrombosis, National Institute of Immunohaematology (ICMR), KEM Hospital, Mumbai, India.
² Department of Hemostasis and Thrombosis, National Institute of Immunohaematology (ICMR), KEM Hospital, Mumbai, India. Electronic address: shrimatishetty@yahoo.com.

PMID: 30502565
DOI: 10.1016/j.bcmd.2018.11.004

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies / adverse effects*
C2 Domains / immunology
Factor VIII / antagonists & inhibitors
Factor VIII / immunology*
Hemophilia A / immunology*
Humans
India
Protein Domains / immunology

Substances

Antibodies
Factor VIII